These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1487203)

  • 21. [A case of severe bronchial asthma following first use of timolol ophthalmic solution].
    Inamizu T; Yoshikawa M; Murai H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):385-9. PubMed ID: 8315910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Timolol eye drops in the treatment of glaucoma and ocular hypertension. A multicentre study].
    Nielsen NV; Eriksen JS; Larsen G; Mortensen KK; Kemp A; Andersen F; Buhl H; Olsen J; Dalsgård C; Frandsen E; Vase I; Glissov B; Pugesgaard T; Jensen S; Heuer HE
    Ugeskr Laeger; 1981 Mar; 143(13):802-5. PubMed ID: 7027564
    [No Abstract]   [Full Text] [Related]  

  • 23. Ophthalmic Timolol Hallucinations: A Case Series and Review of the Literature.
    Nanda T; Rasool N; Callahan AB; Stamper RL; Odel JG
    J Glaucoma; 2017 Sep; 26(9):e214-e216. PubMed ID: 28671925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allergic contact dermatitis from timolol and dorzolamide eye drops.
    Kalavala M; Statham BN
    Contact Dermatitis; 2006 Jun; 54(6):345. PubMed ID: 16787459
    [No Abstract]   [Full Text] [Related]  

  • 25. Pulmonary effects of topical timolol.
    Charan NB; Lakshminarayan S
    Arch Intern Med; 1980 Jun; 140(6):843-4. PubMed ID: 7387281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential systemic and ocular side effects associated with topical administration of timolol maleate.
    Trawick AB
    J Am Optom Assoc; 1985 Feb; 56(2):108-12. PubMed ID: 3980902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe hyperkalemia as a complication of timolol, a topically applied beta-adrenergic antagonist.
    Swenson ER
    Arch Intern Med; 1986 Jun; 146(6):1220-1. PubMed ID: 3718111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Minimizing the systemic effects of glaucoma medications.
    Farrell TA
    Geriatrics; 1991 May; 46(5):61-4, 73. PubMed ID: 2029975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of systemic blockade of beta-blockers eyedrops].
    Sirbat D; George JL; Mayeux D; Saudax E; Kohler C; Levan D; Grilliat JP
    Bull Soc Ophtalmol Fr; 1987; 87(7-8):873-8. PubMed ID: 2827902
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of topical 0.5% timolol on tear flow in patients with primary open-angle glaucoma as assessed by fluorophotometry.
    Göbbels M; Mönks T; Spitznas M
    Ger J Ophthalmol; 1993 Aug; 2(4-5):241-5. PubMed ID: 8220106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skin reactions due to eye drops: report of two cases.
    Lazarov A; Amichai B
    Cutis; 1996 Nov; 58(5):363-4. PubMed ID: 8934079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuation rates of topical glaucoma medications in a managed care population.
    Shaya FT; Mullins CD; Wong W; Cho J
    Am J Manag Care; 2002 Aug; 8(10 Suppl):S271-7. PubMed ID: 12188170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-receptor blocking agents and glaucoma; timolol in eye drops].
    Ros FE; Dake CL; Innemee HC; van Zwieten PA
    Ned Tijdschr Geneeskd; 1981 Mar; 125(11):422-5. PubMed ID: 7219582
    [No Abstract]   [Full Text] [Related]  

  • 34. [Life-threatening status asthmaticus following use of timolol-containing eye drops (Timoptol)].
    de Grood PM; Gimbrère JS
    Ned Tijdschr Geneeskd; 1981 Mar; 125(11):427-9. PubMed ID: 7219583
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness and safety of dorzolamide-timolol alone or combined with latanoprost in open-angle glaucoma or ocular hypertension.
    Lesk MR; Koulis T; Sampalis F; Sampalis JS; Bastien NR
    Ann Pharmacother; 2008 Apr; 42(4):498-504. PubMed ID: 18364402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-month, randomized, double-masked study comparing latanoprost with timolol in pigmentary glaucoma.
    Mastropasqua L; Carpineto P; Ciancaglini M; Gallenga PE
    Ophthalmology; 1999 Mar; 106(3):550-5. PubMed ID: 10080213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [SYNCOPE CAUSED BY INTRA-OCULAR TIMOLOL].
    Eyal A; Braun E; Naffaa ME
    Harefuah; 2015 Nov; 154(11):701-2, 742. PubMed ID: 26821501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric Adverse Events from Topical Ophthalmic Timolol.
    Cimolai N
    Clin Med Res; 2019 Dec; 17(3-4):90-96. PubMed ID: 31462538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can ophthalmic drops cause central nervous system depression and cardiogenic shock in infants?
    Kiryazov K; Stefova M; Iotova V
    Pediatr Emerg Care; 2013 Nov; 29(11):1207-9. PubMed ID: 24196091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical timolol maleate might adversely affect serum lipoproteins.
    Safran AB; Simona F; Sansonetti A; Pometta D; James R
    Int Ophthalmol; 1993 Apr; 17(2):109-10. PubMed ID: 8407117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.